Home Diagnostic Imaging International Corp.

July 19, 2009
Diagnostic Imaging International Corp.; Rated 'Speculative Buy,' Target Price $0.78 by Beacon Equity Research

DALLAS (July 19, 2009) - Diagnostic Imaging International Corp. (OTCBB: DIIG) has been rated Speculative Buy with a price target of $0.78 by Beacon Analyst, Victor Sula, Ph.D.

The full report is available at http://www.beaconequity.com

Anyone interested in receiving alerts regarding DIIG research should e-mail members@beaconequity.com with "DIIG" in the subject line.

In the report, the analyst writes, "DIIG plans to build a network of imaging clinics and is actively pursuing acquisitions of existing, profitable private clinics in major metropolitan areas across Canada, while expanding its CTS business segment. The Company plans to focus primarily on Magnetic Resonance Imaging (MRI) clinics. As its network grows, DIIG may add Computed Tomography (CT) scan equipment to its facilities. É

"In April 2009, CTS secured contracts to supply teleradiology services to 10 additional hospitals in Ontario. Night time and weekend service has already begun, and early feedback from the hospitals has been very positive. With these new contracts, CTS expects to double monthly study reads, significantly expand revenues and quickly achieve profitability."

Other companies providing radiology technology services: NightHawk Radiology Holdings Inc. (NHWK), Virtual Radiologic Corp. (VRAD0, Health Fitness Corp. (FIT) and RadNet Inc. (RDNT).

BeaconEquity Research Disclosure
The analysts contributing to this report certify that the views expressed herein accurately reflect the analysts' personal views as to the subject securities and issuers. BeaconEquity.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity is a Web site wholly owned by BlueWave Advisors, which has been compensated five thousand five hundred dollars directly from DIIG, as a marketing budget to manage a comprehensive investor awareness program including the creation and distribution of this report as well as other investor relations efforts. This report is based on data obtained from sources we believe to be reliable, but is not guaranteed as to accuracy and does not purport to be complete. Please read our report and visit our Web site, BeaconEquity.com, for complete disclosures.

SOURCE: Diagnostic Imaging International Corp.

Jeff Bishop, (469)-252-3505
Diagnostic Imaging International Corp.
Richard Jagodnik
(866) 233-2005

Product software development with Glorium Technologies 

This web site includes forward-looking statements that reflect Diagnostic Imaging International Corp. and its subsidiary companies' current expectations about its future results, performance, prospects and opportunities. Diagnostic Imaging International Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to Diagnostic Imaging International Corp. and are subject to a number of risks, uncertainties and other factors that could cause Diagnostic Imaging International Corp.'s actual results, performance, prospects or opportunities in the remainder of and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.